Carregant...
Direct-Acting Oral Anticoagulants and Their Reversal Agents—An Update
Background: Over the last ten years, a new class of drugs, known as the direct-acting oral anticoagulants (DOACs), have emerged at the forefront of anticoagulation therapy. Like the older generation anticoagulants, DOACs require specific reversal agents in cases of life-threatening bleeding or the n...
Guardat en:
| Publicat a: | Medicines (Basel) |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6963825/ https://ncbi.nlm.nih.gov/pubmed/31618893 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medicines6040103 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|